These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1495449)

  • 1. [Beta-2-microglobulin in hyperthyroidism].
    Foscolo G; Roiter I; De Menis E; Legovini P; Conte N
    Minerva Endocrinol; 1992; 17(1):1-5. PubMed ID: 1495449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum beta 2-microglobulin concentrations in hyperthyroid states.
    Roiter I; Da Rin G; De Menis E; Foscolo GC; Legovini P; Conte N
    J Clin Pathol; 1991 Jan; 44(1):73-4. PubMed ID: 1997537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does thyroid function influence serum beta 2-microglobulin?
    Mulder H; Fischer HR
    Neth J Med; 1989 Apr; 34(3-4):182-8. PubMed ID: 2657455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism.
    Stott DJ; McLellan AR; Finlayson J; Chu P; Alexander WD
    Q J Med; 1991 Jan; 78(285):77-84. PubMed ID: 1670067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthyroidism and the heart: study of left ventricular function in preclinical hyperthyroidism.
    Földes J; Istvánffy M; Halmágyi M; Váradi A; Lakatos P; Pártos O
    Acta Med Hung; 1986; 43(1):23-9. PubMed ID: 3774416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
    De Bellis A; Bizzarro A; Gattoni A; Romano C; Di Martino S; Sinisi AA; Abbadessa S; Bellastella A
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-microsomal, anti-thyroglobulin antibodies and thyroid stimulants in hyperthyroid subjects. Analysis of 315 patients followed-up for 3 years at a single medical center].
    Morosini P; Arnaldi G; Taccaliti A; Mancini V; Filipponi S; Giacchetti G; Petrelli MD; Simonella G; Maniscalco L
    Recenti Prog Med; 1994 Nov; 85(11):521-5. PubMed ID: 7855385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of the clinical picture, hormonal status and humoral immunity in older patients with diffuse toxic goiter].
    Natarov VV; Grinchenko TS; Afanas'eva NI; Pesotskaia PM; Nikolaeva VM
    Ter Arkh; 1988; 60(12):96-8. PubMed ID: 3247664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
    Rink T; Dembowski W; Schroth HJ; Klinger K
    Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of serum thyrotropic hormone level by 'supersensitive' immunoradiometric assay in functioning thyroid adenoma.
    Földes J; Bános C; Csillag J; Lakatos P; Tarján G
    Acta Med Hung; 1987; 44(4):329-36. PubMed ID: 3127807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta 2-microglobulin levels in thyroid diseases.
    Lervang HH; Møller-Petersen J; Ditzel J
    J Intern Med; 1989 Oct; 226(4):261-4. PubMed ID: 2681507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of subclinical hyperthyroidism].
    Galofré JC
    Rev Med Univ Navarra; 2007; 51(1):18-22. PubMed ID: 17555116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual events preceding hyperthyroidism with diffuse goiter.
    Bendezu R; Wieland RG; Tang P; Levine B
    Arch Intern Med; 1977 Aug; 137(8):1023-5. PubMed ID: 577670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter].
    Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of plasma thyrotrophin response to thyrotrophin releasing hormone in Graves' disease and in hyperactive thyroid adenoma before and after treatment.
    Faglia G; Ferrari C; Beck-Peccoz P; Ambrosi B; Spada A; Travaglini P; Paracchi A
    Folia Endocrinol; 1973 Aug; 26(4):245-56. PubMed ID: 4203132
    [No Abstract]   [Full Text] [Related]  

  • 20. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A; Fröss K; Kostecka-Matyja M; Sowa-Staszczak A; Szybiński Z; Huszno B; Ptak M
    Przegl Lek; 2003; 60(11):768-71. PubMed ID: 15058054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.